AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Trajek Injection

Prescription Icon
Prescription Required

Marketer

Suncure Lifescience Pvt Ltd

Salt Composition

Tranexamic Acid (500mg)

Overview Trajek Injection

Hemostatic therapy with Trajek Injection effectively manages bleeding episodes. Its application spans various procedures and conditions, including dental extractions, menorrhagia, abnormal uterine bleeding, epistaxis, and surgeries involving the oral cavity, prostate, or bladder. Trajek Injection's anti-fibrinolytic action inhibits clot dissolution, thus controlling hemorrhage. Administration should always be conducted under medical guidance. Prior allergies to Trajek Injection contraindicate its use. Frequently reported side effects encompass injection site reactions, fatigue, musculoskeletal discomfort, and nasal stuffiness. Patients with a history of cardiac surgery or kidney impairment should disclose this information to their physician prior to treatment. Trajek Injection is deemed safe for use during pregnancy and lactation, as well as in individuals with liver disease.

Uses of Trajek Injection

Managing Hemorrhage

Major Benefits of Trajek Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Trajek Injection:

  • Joint pain
  • Headache
  • Back pain
  • Vomiting
  • Nausea
  • Abdominal pain
  • Diarrhea
  • Muscle cramp
  • Anemia (low number of red blood cells)
  • Lightheadedness

How to use Trajek Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

How Trajek Injection works:

Trajek Injection is a medication that inhibits fibrinolysis. Its mechanism of action involves preventing clot dissolution, thereby managing heavy menstrual bleeding or post-surgical hemorrhage.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Trajek Injection and alcohol can lead to significant somnolence.

PregnancyPregnancyCONSULT YOUR DOCTOR

Data on Trajek Injection use in pregnancy is lacking. Seek medical advice from your physician.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Trajek Injection while breastfeeding is likely inadvisable. Preliminary evidence in humans indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCONSULT YOUR DOCTOR

Trajek Injection's impact on driving ability is undetermined. Refrain from operating a vehicle if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyCAUTION

For individuals with impaired kidney function, Trajek Injection requires careful administration. The prescribed dosage of Trajek Injection might require modification. A physician's consultation is recommended.

LiverLiverSAFE IF PRESCRIBED

The use of Trajek Injection in individuals with hepatic impairment appears to pose minimal risk. Current evidence indicates dose modification may be unnecessary, though further research is warranted. Physician consultation is recommended.

What if you forget to take Trajek Injection :

Omit a Trajek Injection dose? Seek your physician's advice.

Facts to Know About Trajek Injection

LabelValue
Chemical Type Amino Acid and Peptide Analogs
Developing Habits No.
Treatment Category KINSHIP

FAQs on Trajek Injection

Trajek Injection must be administered intravenously, via slow injection only. Intramuscular injection is contraindicated to minimize adverse effects.
All medications carry potential side effects, though these are less likely when taken as prescribed. The benefits typically outweigh the risks. However, Trajek Injection may rarely cause serious, potentially dangerous side effects such as anaphylaxis (characterized by rash, breathing difficulties, and facial/oral/eyelid swelling), blood clots, or vision problems. Always consult your doctor before starting this medication and adhere strictly to their instructions.
Trajek Injection helps stop bleeding by promoting blood clotting. Rarely, this can cause deep vein thrombosis (DVT), a blood clot in the leg. Studies suggest other factors may contribute to this risk, which appears higher in women using Trajek Injection. Consult your doctor before and during treatment, following all instructions carefully.
Prolonged Trajek Injection treatment may affect your color vision. Regular eye exams are therefore recommended, and any vision changes should be reported to your doctor immediately. They may then discontinue the medication and prescribe an alternative.
Trajek Injection accelerates blood clotting, though rarely, this can lead to a potentially fatal blood clot traveling to the lungs (pulmonary embolism). While uncommon, pulmonary embolism risk with Trajek Injection is elevated in cases of overdose, prolonged immobility, or predisposed individuals. Other contributing risk factors may also increase the likelihood of clot formation.
Take Trajek Injection with or without food, swallowing it whole with water. Do not crush or chew the injection.
Dosage and treatment length for this medication vary depending on the condition being treated. For heavy menstrual bleeding, a typical course is five days. For other conditions, the prescribing doctor determines the duration, which may be shorter or longer than five days.
Trajek Injection does not impact fertility. Prescribed for heavy menstrual bleeding, it shows no evidence of interfering with ovulation. Consequently, it's not a contraceptive and won't affect pregnancy chances.
Trajek Injection can effectively stop nosebleeds by promoting blood clotting. For recurrent nosebleeds, a week-long course may be considered.
Trajek Injection
55
MRP 64
14% off